FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966707118> ?p ?o ?g. }

• W1966707118 endingPage "93" @default.
• W1966707118 startingPage "85" @default.
• W1966707118 abstract "To assess the evolving problem of therapeutic drug resistances among enterococci, we organized a comprehensive national (United States) surveillance trial using 99 recruited microbiology laboratories in 48 of the 49 contiguous states or districts. All but two sites completed the protocol that generated information from nearly 2000 enterococci, usually isolated from blood cultures. All strains were speciated by the same method (API 20S) and were susceptibility tested by three methods (broth microdilution, disk diffusion, and Etest) against ampicillin, penicillin, vancomycin, teicoplanin, gentamicin, and streptomycin. Strains resistant to a glycopeptide or penicillin, or possessing high-level aminoglycoside resistance were referred to the monitor's laboratory for validation and additional susceptibility testing against other alternative antimicrobial agents. The most common species were Enterococcus faecalis and Enterococcus faecium. However, antimicrobial resistance occurred most often among the E. faecium isolates. Twenty-three percent of participant centers (22 sites) reported 87 vancomycin-resistant isolates, which accounts for 4.4% of the isolates evaluated. A recent audit (March 1994) of the laboratories not reporting vancomycin resistance during the study interval (October–December 1992) revealed that 61% of sites have now recognized these strains, a threefold increase in 12–15 months. Teicoplanin remained active against 28% (Van B phenotype) of vancomycin-resistant enterococci (10 E. faecalis, 13 E. faecium, and one Enterococcus spp.). Ampicillin-resistant β-lactamase-positive strains were found only at one medical center (two strains, 0.2% of referred or validated strains); however, ampicillin-resistant strains represented 12% of all enterococcal, but nearly 60% of E. faecium strains. Aminoglycoside resistance was: gentamicin 27% and streptomycin 36% of strains. The susceptibility to alternative drugs was: ciprofloxacin 25%, erythromycin 3%, trimethoprim/sulfamethoxazole 22%, and spectinomycin 97%. All National Committee for Clinical Laboratory Standards tests and interpretive criteria performed well. Other drugs worthy of therapeutic consideration include chloramphenicol, tetracyclines (especially doxycycline), novobiocin, trospectomycin or kanamycin as a co-drug, and some newer fluoroquinolones (sparfloxacin and clinafloxacin). Because of this rapidly evolving problem of drug-resistant invasive enterococcal infections, new alternative combination regimens require immediate consideration for structured clinical trials." @default.
• W1966707118 created "2016-06-24" @default.
• W1966707118 creator A5001415896 @default.
• W1966707118 creator A5030127743 @default.
• W1966707118 creator A5044679653 @default.
• W1966707118 creator A5089371529 @default.
• W1966707118 date "1995-02-01" @default.
• W1966707118 modified "2023-09-24" @default.
• W1966707118 title "Emerging multiply resistant enterococci among clinical isolates I. Prevalence data from 97 medical center surveillance study in the United States" @default.
• W1966707118 cites W1480898504 @default.
• W1966707118 cites W1515680909 @default.
• W1966707118 cites W1581595741 @default.
• W1966707118 cites W1624353122 @default.
• W1966707118 cites W1652574726 @default.
• W1966707118 cites W1667417607 @default.
• W1966707118 cites W1759011904 @default.
• W1966707118 cites W1854943655 @default.
• W1966707118 cites W1904634031 @default.
• W1966707118 cites W1908690859 @default.
• W1966707118 cites W1967497559 @default.
• W1966707118 cites W1968199800 @default.
• W1966707118 cites W1985725647 @default.
• W1966707118 cites W1990753221 @default.
• W1966707118 cites W2001824337 @default.
• W1966707118 cites W2002520544 @default.
• W1966707118 cites W2009889907 @default.
• W1966707118 cites W2013402390 @default.
• W1966707118 cites W2023405413 @default.
• W1966707118 cites W2041857268 @default.
• W1966707118 cites W2052060337 @default.
• W1966707118 cites W2058215092 @default.
• W1966707118 cites W2064937233 @default.
• W1966707118 cites W2072749218 @default.
• W1966707118 cites W2074968287 @default.
• W1966707118 cites W2081130840 @default.
• W1966707118 cites W2081253489 @default.
• W1966707118 cites W2084585664 @default.
• W1966707118 cites W2087849810 @default.
• W1966707118 cites W2097629829 @default.
• W1966707118 cites W2108715876 @default.
• W1966707118 cites W2111027368 @default.
• W1966707118 cites W2113876803 @default.
• W1966707118 cites W2123702680 @default.
• W1966707118 cites W2136167568 @default.
• W1966707118 cites W2139863721 @default.
• W1966707118 cites W2164997544 @default.
• W1966707118 doi "https://doi.org/10.1016/0732-8893(94)00147-o" @default.
• W1966707118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7628198" @default.
• W1966707118 hasPublicationYear "1995" @default.
• W1966707118 type Work @default.
• W1966707118 sameAs 1966707118 @default.
• W1966707118 citedByCount "139" @default.
• W1966707118 countsByYear W19667071182012 @default.
• W1966707118 countsByYear W19667071182013 @default.
• W1966707118 countsByYear W19667071182014 @default.
• W1966707118 countsByYear W19667071182015 @default.
• W1966707118 countsByYear W19667071182019 @default.
• W1966707118 countsByYear W19667071182020 @default.
• W1966707118 countsByYear W19667071182022 @default.
• W1966707118 crossrefType "journal-article" @default.
• W1966707118 hasAuthorship W1966707118A5001415896 @default.
• W1966707118 hasAuthorship W1966707118A5030127743 @default.
• W1966707118 hasAuthorship W1966707118A5044679653 @default.
• W1966707118 hasAuthorship W1966707118A5089371529 @default.
• W1966707118 hasConcept C174802600 @default.
• W1966707118 hasConcept C176947019 @default.
• W1966707118 hasConcept C2775832221 @default.
• W1966707118 hasConcept C2776021129 @default.
• W1966707118 hasConcept C2776703206 @default.
• W1966707118 hasConcept C2777677444 @default.
• W1966707118 hasConcept C2778980435 @default.
• W1966707118 hasConcept C2779489039 @default.
• W1966707118 hasConcept C2779895986 @default.
• W1966707118 hasConcept C2780585763 @default.
• W1966707118 hasConcept C2780950330 @default.
• W1966707118 hasConcept C4937899 @default.
• W1966707118 hasConcept C501593827 @default.
• W1966707118 hasConcept C523546767 @default.
• W1966707118 hasConcept C54355233 @default.
• W1966707118 hasConcept C71924100 @default.
• W1966707118 hasConcept C81396022 @default.
• W1966707118 hasConcept C86803240 @default.
• W1966707118 hasConcept C89423630 @default.
• W1966707118 hasConcept C94665300 @default.
• W1966707118 hasConceptScore W1966707118C174802600 @default.
• W1966707118 hasConceptScore W1966707118C176947019 @default.
• W1966707118 hasConceptScore W1966707118C2775832221 @default.
• W1966707118 hasConceptScore W1966707118C2776021129 @default.
• W1966707118 hasConceptScore W1966707118C2776703206 @default.
• W1966707118 hasConceptScore W1966707118C2777677444 @default.
• W1966707118 hasConceptScore W1966707118C2778980435 @default.
• W1966707118 hasConceptScore W1966707118C2779489039 @default.
• W1966707118 hasConceptScore W1966707118C2779895986 @default.
• W1966707118 hasConceptScore W1966707118C2780585763 @default.
• W1966707118 hasConceptScore W1966707118C2780950330 @default.
• W1966707118 hasConceptScore W1966707118C4937899 @default.
• W1966707118 hasConceptScore W1966707118C501593827 @default.
• W1966707118 hasConceptScore W1966707118C523546767 @default.

• next